Gerhard Hoffmann

1.2k total citations
30 papers, 750 citations indexed

About

Gerhard Hoffmann is a scholar working on Epidemiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gerhard Hoffmann has authored 30 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gerhard Hoffmann's work include Influenza Virus Research Studies (9 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Gerhard Hoffmann is often cited by papers focused on Influenza Virus Research Studies (9 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Gerhard Hoffmann collaborates with scholars based in Switzerland, United States and Germany. Gerhard Hoffmann's co-authors include Eric Prinssen, Barbara Donner, Vis Niranjan, Neil Parrott, Craig R. Rayner, Thomas P. Singer, Thierry Lavé, Lothar Lindemann, Alexander Breidenbach and Lauren Boak and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Gerhard Hoffmann

27 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard Hoffmann Switzerland 13 245 203 146 108 85 30 750
H. Krüger Germany 15 143 0.6× 151 0.7× 143 1.0× 93 0.9× 63 0.7× 24 1.1k
Rolf Pokorny Switzerland 16 89 0.4× 215 1.1× 135 0.9× 72 0.7× 63 0.7× 23 969
Shiro Ikawa Japan 15 197 0.8× 150 0.7× 144 1.0× 53 0.5× 23 0.3× 39 785
Michael Steffens Germany 19 157 0.6× 290 1.4× 139 1.0× 63 0.6× 99 1.2× 60 1.1k
Jerzy Trojnar Sweden 16 146 0.6× 464 2.3× 163 1.1× 148 1.4× 113 1.3× 36 1.3k
Jodi L. Miller United Kingdom 16 144 0.6× 579 2.9× 193 1.3× 126 1.2× 50 0.6× 31 1.2k
Mei‐Ping Chang United States 20 192 0.8× 840 4.1× 98 0.7× 71 0.7× 72 0.8× 57 1.6k
Karen Sims United States 17 291 1.2× 232 1.1× 222 1.5× 41 0.4× 163 1.9× 43 968
H Wachter Austria 19 194 0.8× 349 1.7× 135 0.9× 72 0.7× 119 1.4× 59 1.2k
Linda G. Byrd United States 10 126 0.5× 176 0.9× 132 0.9× 35 0.3× 136 1.6× 16 797

Countries citing papers authored by Gerhard Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Gerhard Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Hoffmann more than expected).

Fields of papers citing papers by Gerhard Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Hoffmann. The network helps show where Gerhard Hoffmann may publish in the future.

Co-authorship network of co-authors of Gerhard Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Hoffmann. A scholar is included among the top collaborators of Gerhard Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Hoffmann. Gerhard Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frances, Nicolas, et al.. (2016). Combining Nonclinical Experiments with Translational PKPD Modeling to Differentiate Erlotinib and Gefitinib. Molecular Cancer Therapeutics. 15(12). 3110–3119. 10 indexed citations
2.
Poirier, Agnès, Sara Belli, Christoph Funk, et al.. (2012). Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies. Drug Metabolism and Disposition. 40(8). 1556–1565. 14 indexed citations
3.
Freichel, Christian, Alexander Breidenbach, Gerhard Hoffmann, et al.. (2012). Absence of Central Nervous System and Hypothermic Effects after Single Oral Administration of High Doses of Oseltamivir in the Rat. Basic & Clinical Pharmacology & Toxicology. 111(1). 50–57. 7 indexed citations
4.
Parrott, Neil, Brian E. Davies, Gerhard Hoffmann, et al.. (2011). Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants. Clinical Pharmacokinetics. 50(9). 613–623. 87 indexed citations
5.
Lindemann, Lothar, Georg Jaeschke, Aubin Michalon, et al.. (2011). CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 339(2). 474–486. 91 indexed citations
6.
Freichel, Christian, Alexander Breidenbach, Thomas Weiser, et al.. (2011). Lack of Unwanted Effects of Oseltamivir Carboxylate in Juvenile Rats after Subcutaneous Administration. Basic & Clinical Pharmacology & Toxicology. 110(6). 551–553. 2 indexed citations
7.
Donner, Barbara, Vis Niranjan, & Gerhard Hoffmann. (2010). Safety of Oseltamivir in Pregnancy. Drug Safety. 33(8). 631–642. 52 indexed citations
8.
Toovey, Stephen, Craig R. Rayner, Eric Prinssen, et al.. (2008). Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir. Drug Safety. 31(12). 1097–1114.
9.
Toovey, Stephen, Craig R. Rayner, Eric Prinssen, et al.. (2008). Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir. Drug Safety. 31(12). 1097–1114. 126 indexed citations
10.
Hofmann, Ilona, Nina Wunderlich, Greg Robertson, et al.. (2007). Percutaneous injection of thrombin for the treatment of pseudoaneurysms: the German multicentre registry. EuroIntervention. 3(3). 321–326. 20 indexed citations
11.
Nasterlack, Michael, et al.. (2006). Epidemiological and clinical investigations among employees in a former herbicide production process. International Archives of Occupational and Environmental Health. 80(3). 234–238. 4 indexed citations
12.
Hoffmann, Gerhard. (2005). From Modernism to Postmodernism: Concepts and Strategies of Postmodern American Fiction. Medical Entomology and Zoology. 22 indexed citations
13.
Higgins, Brian, Kenneth Kolinsky, Melissa Smith, et al.. (2004). Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models. Anti-Cancer Drugs. 15(5). 503–512. 126 indexed citations
14.
Hoffmann, Gerhard, et al.. (1997). Emotion in Postmodernism. Medical Entomology and Zoology. 5 indexed citations
15.
Hoffmann, Gerhard, et al.. (1996). Ethics and aesthetics: The moral turn of postmodernism. 9 indexed citations
16.
Hanzal, E., Gerhard Hoffmann, & H. Kölbl. (1992). Drogensucht, Rauchen und fetale Wachstumsretardation. Geburtshilfe und Frauenheilkunde. 52(7). 430–433. 1 indexed citations
17.
Bieglmayer, Christian, et al.. (1991). CA15.3, MCA, CAM26, CAM29 Are Members of a Polymorphic Family of Mucin-Like Glycoproteins. Tumor Biology. 12(3). 138–148. 20 indexed citations
18.
Hoffmann, Gerhard, et al.. (1975). Holographic memories. 535–535. 5 indexed citations
19.
Hoffmann, Gerhard, et al.. (1975). Wie können Tunten Sozialisten sein?. PROKLA Zeitschrift für kritische Sozialwissenschaft. 5(17/18). 57–94. 1 indexed citations
20.
Hoffmann, Gerhard. (1951). An Hypothesis Regarding the Scope and Limitations of Psychotherapy. American Journal of Psychotherapy. 5(3). 339–361. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Krüger Breakdown of academic impact, for papers by Rolf Pokorny Breakdown of academic impact, for papers by Shiro Ikawa Breakdown of academic impact, for papers by Michael Steffens Breakdown of academic impact, for papers by Jerzy Trojnar Breakdown of academic impact, for papers by Jodi L. Miller Breakdown of academic impact, for papers by Mei‐Ping Chang Breakdown of academic impact, for papers by Karen Sims Breakdown of academic impact, for papers by H Wachter Breakdown of academic impact, for papers by Linda G. Byrd
Rankless by CCL
2026